DFCM
CERE

Dark Forest Capital Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Dark Forest Capital Management’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-7,846
Closed -$321K – 1215
2024
Q2 		$321K Sell
7,846
-21,077
-73% -$878K 0.06% 420
2024
Q1 		$1.22M Buy
+28,923
New +$1.21M 0.21% 92
2023
Q4 		– Sell
-12,247
Closed -$267K – 1168
2023
Q3 		$267K Buy
+12,247
New +$306K 0.02% 944
2023
Q2 		– Sell
-3,093
Closed -$75.4K – 1496
2023
Q1 		$75.4K Buy
+3,093
New +$90.8K 0.02% 747
2022
Q4 		– Sell
-3,070
Closed -$87K – 1560
2022
Q3 		$87K Buy
3,070
+3,068
+153,400% +$91.4K 0.01% 482
2022
Q2 		$0 Buy
+2
New +$57 ﹤0.01% 1487

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Dark Forest Capital Management's CERE Position: Q3 2024 in Review

Dark Forest Capital Management sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 7,846 shares — an estimated $321K sold.

Dark Forest Capital Management first reported a position in CERE in Q2 2022 and held it in 6 quarters. The position peaked at $1.22M in Q1 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • Dark Forest Capital Management reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Dark Forest Capital Management sold 7,846 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $321K.
  • Dark Forest Capital Management first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q2 2022 and held it in 6 quarters.
  • Dark Forest Capital Management's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $1.22M in Q1 2024.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Dark Forest Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.